Universal Biosensors, Inc. (ASX:UBIO)
Australia
· Delayed Price · Currency is AUD 0.0400
0.00 (0.00%)
At close: Dec 13, 2024
Universal Biosensors Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 6.28 | 6.63 | 4.52 | 5.78 | 3.2 | Upgrade
|
| Revenue Growth (YoY) | -5.28% | 46.58% | -21.68% | 80.41% | -53.57% | Upgrade
|
| Cost of Revenue | 2.28 | 2.35 | 2.39 | 3.67 | 2.58 | Upgrade
|
| Gross Profit | 4 | 4.28 | 2.14 | 2.11 | 0.62 | Upgrade
|
| Selling, General & Admin | 16.03 | 15.17 | 11.35 | 6.05 | 6.42 | Upgrade
|
| Research & Development | 4.13 | 4.84 | 12.02 | 8.92 | 4.53 | Upgrade
|
| Operating Expenses | 20.97 | 20.97 | 26.02 | 17.14 | 13.18 | Upgrade
|
| Operating Income | -16.97 | -16.68 | -23.88 | -15.04 | -12.56 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.02 | - | - | Upgrade
|
| Interest & Investment Income | 0.45 | 0.73 | 0.38 | 0.05 | 0.29 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.03 | -0.12 | 0.27 | -0.17 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.31 | 9.23 | 4.74 | 4.05 | 2.86 | Upgrade
|
| EBT Excluding Unusual Items | -14.24 | -6.76 | -18.89 | -10.66 | -9.58 | Upgrade
|
| Asset Writedown | - | - | -11.01 | - | - | Upgrade
|
| Other Unusual Items | - | 0.02 | - | 0.15 | 1.27 | Upgrade
|
| Pretax Income | -14.24 | -6.74 | -29.91 | -10.51 | -7.64 | Upgrade
|
| Income Tax Expense | - | - | -3.05 | - | - | Upgrade
|
| Net Income | -14.24 | -6.74 | -26.85 | -10.51 | -7.64 | Upgrade
|
| Net Income to Common | -14.24 | -6.74 | -26.85 | -10.51 | -7.64 | Upgrade
|
| Shares Outstanding (Basic) | 270 | 212 | 199 | 178 | 178 | Upgrade
|
| Shares Outstanding (Diluted) | 270 | 212 | 199 | 178 | 178 | Upgrade
|
| Shares Change (YoY) | 27.32% | 6.87% | 11.82% | 0.08% | 0.05% | Upgrade
|
| EPS (Basic) | -0.05 | -0.03 | -0.14 | -0.06 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.03 | -0.14 | -0.06 | -0.04 | Upgrade
|
| Free Cash Flow | -12.71 | -16.09 | -16.27 | -10.56 | -8.68 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.08 | -0.08 | -0.06 | -0.05 | Upgrade
|
| Gross Margin | 63.70% | 64.60% | 47.27% | 36.45% | 19.46% | Upgrade
|
| Operating Margin | -270.08% | -251.48% | -527.72% | -260.28% | -392.12% | Upgrade
|
| Profit Margin | -226.65% | -101.64% | -593.48% | -181.85% | -238.49% | Upgrade
|
| Free Cash Flow Margin | -202.35% | -242.62% | -359.50% | -182.79% | -270.97% | Upgrade
|
| EBITDA | -16.17 | -15.71 | -21.09 | -12.47 | -10.13 | Upgrade
|
| EBITDA Margin | -257.30% | -236.86% | - | -215.85% | - | Upgrade
|
| D&A For EBITDA | 0.8 | 0.97 | 2.79 | 2.57 | 2.43 | Upgrade
|
| EBIT | -16.97 | -16.68 | -23.88 | -15.04 | -12.56 | Upgrade
|
| EBIT Margin | -270.08% | -251.48% | - | -260.28% | - | Upgrade
|
| Revenue as Reported | 6.28 | 6.63 | 4.52 | 5.78 | 3.2 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.